<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Cell Proteomics</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Cell Proteomics</journal-id>
<journal-id journal-id-type="hwp">mcprot</journal-id>
<journal-id journal-id-type="pmc">mcprot</journal-id>
<journal-id journal-id-type="publisher-id">MCP</journal-id>
<journal-title-group>
<journal-title>Molecular &amp; Cellular Proteomics : MCP</journal-title>
</journal-title-group>
<issn pub-type="ppub">1535-9476</issn>
<issn pub-type="epub">1535-9484</issn>
<publisher>
<publisher-name>The American Society for Biochemistry and Molecular Biology</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30630936</article-id>
<article-id pub-id-type="pmc">6442360</article-id>
<article-id pub-id-type="publisher-id">RA118.000992</article-id>
<article-id pub-id-type="doi">10.1074/mcp.RA118.000992</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection<xref ref-type="fn" rid="FN1">*</xref><xref ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"></inline-graphic></sup></xref></article-title>
<alt-title alt-title-type="short">Epitope Profiling of Malaria Antibodies Using Peptide Arrays</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jaenisch</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
<xref ref-type="aff" rid="aff3">¶</xref>
<xref ref-type="author-notes" rid="FN3">‖‖‖</xref>
<xref ref-type="corresp" rid="cor1">‡‡‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Heiss</surname>
<given-names>Kirsten</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
<xref ref-type="author-notes" rid="FN3">‖‖‖</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fischer</surname>
<given-names>Nico</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
<xref ref-type="aff" rid="aff3">¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geiger</surname>
<given-names>Carolin</given-names>
</name>
<xref ref-type="aff" rid="aff1">‡</xref>
<xref ref-type="aff" rid="aff2">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bischoff</surname>
<given-names>F. Ralf</given-names>
</name>
<xref ref-type="aff" rid="aff4">‖</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moldenhauer</surname>
<given-names>Gerhard</given-names>
</name>
<xref ref-type="aff" rid="aff4">‖</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rychlewski</surname>
<given-names>Leszek</given-names>
</name>
<xref ref-type="aff" rid="aff5">**</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sié</surname>
<given-names>Ali</given-names>
</name>
<xref ref-type="aff" rid="aff6">‡‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coulibaly</surname>
<given-names>Boubacar</given-names>
</name>
<xref ref-type="aff" rid="aff6">‡‡</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seeberger</surname>
<given-names>Peter H.</given-names>
</name>
<xref ref-type="aff" rid="aff7">§§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wyrwicz</surname>
<given-names>Lucjan S.</given-names>
</name>
<xref ref-type="aff" rid="aff8">¶¶</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Breitling</surname>
<given-names>Frank</given-names>
</name>
<xref ref-type="aff" rid="aff9">‖‖</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loeffler</surname>
<given-names>Felix F.</given-names>
</name>
<xref ref-type="aff" rid="aff3">¶</xref>
<xref ref-type="aff" rid="aff7">§§</xref>
<xref ref-type="corresp" rid="cor2">¶¶¶</xref>
</contrib>
<aff id="aff1">From the ‡Center for Infectious Diseases, Parasitology Unit, Heidelberg University Hospital, Im Neuenheimer Feld 324, D 69120 Heidelberg, Germany; </aff>
<aff id="aff2">§German Center for Infectious Disease Research, Heidelberg (DZIF); </aff>
<aff id="aff3">¶HEiKA - Heidelberg Karlsruhe Research Partnership, Heidelberg University, Karlsruhe Institute of Technology (KIT), Germany; </aff>
<aff id="aff4">‖German Cancer Research Center, Im Neuenheimer Feld 280, D 69120 Heidelberg, Germany; </aff>
<aff id="aff5">**BioInfoBank Institute, Św. Marcin 80/82 lok. 355, 61-809 Poznań, Poland; </aff>
<aff id="aff6">‡‡Centre de Recherche en Santé de Nouna, BP 02 Nouna, Rue Namory Keita, Burkina Faso; </aff>
<aff id="aff7">§§Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, D 14476 Potsdam, Germany; </aff>
<aff id="aff8">¶¶Department of Oncology and Radiotherapy, M Sklodowska Curie Memorial Cancer Center, Wawelska 15, 02–034 Warsaw, Poland; </aff>
<aff id="aff9">‖‖Institute of Microstructure Technology, Karlsruhe Institute of Technology, Germany Hermann-von-Helmholtz-Platz 1, D 76344 Eggenstein-Leopoldshafen, Germany</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">‡‡‡ To whom correspondence may be addressed:
<addr-line>Center for Infectious Diseases, Parasitology Unit, Heidelberg University Hospital, Im Neuenheimer Feld 324, D 69120 Heidelberg, Germany.</addr-line> E-mail:
<email>thomas.jaenisch@urz.uni-heidelberg.de</email>.</corresp>
<corresp id="cor2">¶¶¶ To whom correspondence may be addressed:
<addr-line>Max Planck Institute of Colloids and Interfaces, Am Mühlenberg 1, D 14476 Potsdam, Germany.</addr-line> E-mail:
<email>felix.loeffler@mpikg.mpg.de</email>.</corresp>
<fn fn-type="equal" id="FN3">
<p>‖‖‖ These authors contributed equally to this work.</p>
</fn>
<fn fn-type="con">
<p>Author contributions: T.J., K.H., C.G., G.M., L.R., A.S., B.C., P.H.S., L.S.W., F.B., and F.F.L. designed research; T.J., K.H., N.F., C.G., F.R.B., L.R., L.S.W., and F.F.L. performed research; T.J., K.H., P.H.S., and F.F.L. wrote the paper; K.H., N.F., L.R., L.S.W., and F.F.L. analyzed data; F.R.B., G.M., L.R., A.S., B.C., and F.F.L. contributed new reagents/analytic tools.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>4</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>18</volume>
<issue>4</issue>
<fpage>642</fpage>
<lpage>656</lpage>
<history>
<date date-type="received">
<day>27</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>11</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 Jaenisch et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Jaenisch et al.</copyright-holder>
<license>
<license-p>Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="zjw004195896641.pdf"></self-uri>
<abstract abstract-type="precis">
<p>Within this study, a novel high-throughput peptide array technology enabled the correlation between the clinical phenotype and the antibody response against linear epitopes of the <italic>P. falciparum</italic> proteome. Peptides from twelve known vaccine candidates and a bioinformatical selection were screened. Strong reactivities to epitopes derived from known vaccine candidates as well as new immunogenic proteins/epitopes were identified, which may serve as vaccine targets and new biomarkers.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<fig fig-type="featured" id="F5" orientation="portrait" position="float">
<graphic xlink:href="zjw0041958960005"></graphic>
</fig>
</p>
<p>
<bold>Highlights</bold>
</p>
<p>
<list list-type="bullet">
<list-item>
<p>Profiling antibody responses of patients with naturally acquired malaria immunity.</p>
</list-item>
<list-item>
<p>High-density peptide arrays featuring linear epitopes.</p>
</list-item>
<list-item>
<p>Epitope mapping of known and potential novel vaccine candidates.</p>
</list-item>
<list-item>
<p>Novel immunogenic epitopes discovered, and known antibody target motifs confirmed.</p>
</list-item>
</list>
</p>
</abstract>
<abstract>
<p>High-density peptide arrays are an excellent means to profile anti-plasmodial antibody responses. Different protein intrinsic epitopes can be distinguished, and additional insights are gained, when compared with assays involving the full-length protein. Distinct reactivities to specific epitopes within one protein may explain differences in published results, regarding immunity or susceptibility to malaria. We pursued three approaches to find specific epitopes within important plasmodial proteins, (1) twelve leading vaccine candidates were mapped as overlapping 15-mer peptides, (2) a bioinformatical approach served to predict immunogenic malaria epitopes which were subsequently validated in the assay, and (3) randomly selected peptides from the malaria proteome were screened as a control. Several peptide array replicas were prepared, employing particle-based laser printing, and were used to screen 27 serum samples from a malaria-endemic area in Burkina Faso, West Africa. The immunological status of the individuals was classified as “protected” or “unprotected” based on clinical symptoms, parasite density, and age. The vaccine candidate screening approach resulted in significant hits in all twelve proteins and allowed us (1) to verify many known immunogenic structures, (2) to map B-cell epitopes across the entire sequence of each antigen and (3) to uncover novel immunogenic epitopes. Predicting immunogenic regions in the proteome of the human malaria parasite <italic>Plasmodium falciparum</italic>, via the bioinformatics approach and subsequent array screening, confirmed known immunogenic sequences, such as in the leading malaria vaccine candidate CSP and discovered immunogenic epitopes derived from hypothetical or unknown proteins.</p>
</abstract>
<kwd-group>
<kwd>Antibodies*</kwd>
<kwd>Peptide array</kwd>
<kwd>Peptidomics</kwd>
<kwd>Malaria</kwd>
<kwd>Biomarker: Diagnostic</kwd>
<kwd>epitope mapping</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>
<institution-wrap>
<institution>Carl-Zeiss-Stiftung (Carl Zeiss Stiftung)</institution>
<institution-id>https://dx.doi.org/10.13039/100007569</institution-id>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<name>
<surname>Loeffler</surname>
<given-names>Felix F.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award2">
<funding-source>
<institution-wrap>
<institution>Bundesministerium für Bildung und Forschung (BMBF)</institution>
<institution-id>https://dx.doi.org/10.13039/501100002347</institution-id>
</institution-wrap>
</funding-source>
<award-id>13XP5050A</award-id>
<award-id>031A170A</award-id>
<award-id>03EK3030A</award-id>
<principal-award-recipient>
<name>
<surname>Breitling</surname>
<given-names>Frank</given-names>
</name>
</principal-award-recipient>
<principal-award-recipient>
<name>
<surname>Loeffler</surname>
<given-names>Felix F.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award3">
<funding-source>
<institution-wrap>
<institution>Deutsche Forschungsgemeinschaft (DFG)</institution>
<institution-id>https://dx.doi.org/10.13039/501100001659</institution-id>
</institution-wrap>
</funding-source>
<award-id>HEiKA</award-id>
<award-id>SFB 365</award-id>
<award-id>Graduiertenkolleg 367</award-id>
<principal-award-recipient>
<name>
<surname>Jaenisch</surname>
<given-names>Thomas</given-names>
</name>
</principal-award-recipient>
<principal-award-recipient>
<name>
<surname>Geiger</surname>
<given-names>Carolin</given-names>
</name>
</principal-award-recipient>
<principal-award-recipient>
<name>
<surname>Loeffler</surname>
<given-names>Felix F.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>